---
type: Person
title: Jean Hu-Primmer
description: Person appearing in 7 documents.
tags:
  - person
document_count: 7
first_seen: "2014-07-23T18:25:00"
last_seen: "2014-07-25T10:13:00"
aliases:
  - Jean Hu-Primmer
sources:
  - { id: gates, resource: /sources/gates.md, title: Gates Package, author: "process:senate-hsgac-release", last_modified: 2026-07-31 }
generated: { by: randpaul-corpus-pipeline/1.0, at: "2026-08-01T12:42:27Z" }
status: stable
---

Appears in the COVID-19 subpoena corpus.

# Activity

- **Documents:** 7 (sent/authored 5, received 2)
- **Active:** 2014-07-23 to 2014-07-25

# Correspondents

| Person | Messages | First | Last |
|---|---:|---|---|
| [Gene Olinger](/people/gene-olinger.md) | 3 | 2014-07-24 | 2014-07-25 |
| [Lisa Hensley](/people/lisa-hensley.md) | 3 | 2014-07-24 | 2014-07-25 |
| Anna Honko | 2 | 2014-07-24 | 2014-07-24 |
| [Carmen Maher](/people/carmen-maher.md) | 2 | 2014-07-23 | 2014-07-23 |
| Julian O Rear | 2 | 2014-07-23 | 2014-07-24 |
| Brad G Leissa | 1 | 2014-07-23 | 2014-07-23 |
| Charu Mullick | 1 | 2014-07-23 | 2014-07-23 |
| Eric Donaldson | 1 | 2014-07-23 | 2014-07-23 |
| Gary QIINOtns.cov) I His.cov Disbrow | 1 | 2014-07-23 | 2014-07-23 |
| Kimberly Armstrong | 1 | 2014-07-23 | 2014-07-23 |
| Peter Miele | 1 | 2014-07-23 | 2014-07-23 |
| Rosemary Roberts | 1 | 2014-07-23 | 2014-07-23 |
| Su-Young Choi | 1 | 2014-07-23 | 2014-07-23 |

# Topics

* [Intelligence community assessments](/topics/intelligence-community.md) - 2 documents
* [FOIA, records and transparency](/topics/foia-transparency.md) - 1 documents
* [Therapeutics and treatments](/topics/treatments.md) - 1 documents
* [Vaccines](/topics/vaccines.md) - 1 documents
* [WHO and international investigation](/topics/who-international.md) - 1 documents

# Statement timeline

What this person is recorded saying, in date order, quoted verbatim with page citations.

* **2014-07-23** ([intelligence_community](/topics/intelligence-community.md), instructs): "ICC Form - 2014 PHEMCE MOU.PDF>> Also before we start the any discussion which will include non-public information, we need to state the following per the MOU SOP: "This discussion may include trade secret or confidential commercial information protected…" [^gates]
* **2014-07-23** ([intelligence_community](/topics/intelligence-community.md), asserts): "Participants should not further disclose or otherwise make public the information that is shared." Finally, am happy to be the liaison for our FDA group, and appreciate that you go through me for all of your needs and concerns." [^gates]

# Sources

[^gates]: [gates](/sources/gates.md)